2015 (v1)
Publication
No description
Uploaded on: September 24, 2024
P
R
Last name: PRINAPORI
First name: R.
No description
Objectives: To report the 96 week results on efficacy, safety and bone mineral density (BMD) in subjects with HIV-1 that were virologically suppressed and treated with atazanavir/ritonavir monotherapy versus atazanavir/ ritonavir triple therapy. Methods: MODAt is a prospective, multicentre, open-label, non-inferiority, randomized, 96 week trial...
No description